NOVEL DEATH DOMAIN PROTEINS
    1.
    发明申请
    NOVEL DEATH DOMAIN PROTEINS 审中-公开
    新的死亡蛋白质蛋白

    公开(公告)号:US20110201780A1

    公开(公告)日:2011-08-18

    申请号:US13050848

    申请日:2011-03-17

    IPC分类号: C07K14/295

    摘要: In accordance with the present invention, there are provided novel Death Domain (DD), Death Effector Domain (DED) and NB-ARC domain proteins. The invention also provides nucleic acid molecules encoding DD, DED and NB-ARC domain proteins, vectors containing these nucleic acid molecules and host cells containing the vectors. The invention also provides antibodies that can specifically bind to invention DDs, DEDs or NB-ARC domains. Such DDs, DEDs and NB-ARC domains and/or anti-DD, anti-DED or anti-NB-ARC domain antibodies are useful for discovery of drugs that suppress infection, autoimmunity, inflammation, allergy, allograft rejection, sepsis, and other diseases.

    摘要翻译: 根据本发明,提供了新的死亡域(DD),死亡效应域(DED)和NB-ARC结构域蛋白。 本发明还提供编码DD,DED和NB-ARC结构域蛋白的核酸分子,含有这些核酸分子的载体和含有载体的宿主细胞。 本发明还提供可以特异性结合发明DD,DED或NB-ARC结构域的抗体。 这些DDs,DEDs和NB-ARC结构域和/或抗DD,抗DED或抗NB-ARC结构域抗体可用于发现抑制感染,自身免疫,炎症,过敏,同种异体移植排斥,败血症等的药物 疾病

    NOVEL DEATH DOMAIN PROTEINS
    2.
    发明申请
    NOVEL DEATH DOMAIN PROTEINS 审中-公开
    新的死亡蛋白质蛋白

    公开(公告)号:US20090011501A1

    公开(公告)日:2009-01-08

    申请号:US12134169

    申请日:2008-06-05

    摘要: In accordance with the present invention, there are provided novel Death Domain (DD), Death Effector Domain (DED) and NB-ARC domain proteins. The invention also provides nucleic acid molecules encoding DD, DED and NB-ARC domain proteins, vectors containing these nucleic acid molecules and host cells containing the vectors. The invention also provides antibodies that can specifically bind to invention DDs, DEDs or NB-ARC domains. Such DDs, DEDs and NB-ARC domains and/or anti-DD, anti-DED or anti-NB-ARC domain antibodies are useful for discovery of drugs that suppress infection, autoimmunity, inflammation, allergy, allograft rejection, sepsis, and other diseases.

    摘要翻译: 根据本发明,提供了新的死亡域(DD),死亡效应域(DED)和NB-ARC结构域蛋白。 本发明还提供编码DD,DED和NB-ARC结构域蛋白的核酸分子,含有这些核酸分子的载体和含有载体的宿主细胞。 本发明还提供可以特异性结合发明DD,DED或NB-ARC结构域的抗体。 这些DDs,DEDs和NB-ARC结构域和/或抗DD,抗DED或抗NB-ARC结构域抗体可用于发现抑制感染,自身免疫,炎症,过敏,同种异体移植排斥,败血症等的药物 疾病

    Death domain proteins
    3.
    发明授权
    Death domain proteins 失效
    死亡域蛋白

    公开(公告)号:US06965023B2

    公开(公告)日:2005-11-15

    申请号:US10001254

    申请日:2001-11-15

    摘要: In accordance with the present invention, there are provided novel Death Domain (DD), Death Effector Domain (DED) and NB-ARC domain proteins. The invention also provides nucleic acid molecules encoding DD, DED and NB-ARC domain proteins, vectors containing these nucleic acid molecules and host cells containing the vectors. The invention also provides antibodies that can specifically bind to invention DDs, DEDs or NB-ARC domains. Such DDs, DEDs and NB-ARC domains and/or anti-DD, anti-DED or anti-NB-ARC domain antibodies are useful for discovery of drugs that suppress infection, autoimmunity, inflammation, allergy, allograft rejection, sepsis, and other diseases.

    摘要翻译: 根据本发明,提供了新的死亡域(DD),死亡效应域(DED)和NB-ARC结构域蛋白。 本发明还提供编码DD,DED和NB-ARC结构域蛋白的核酸分子,含有这些核酸分子的载体和含有载体的宿主细胞。 本发明还提供可以特异性结合发明DD,DED或NB-ARC结构域的抗体。 这些DDs,DEDs和NB-ARC结构域和/或抗DD,抗DED或抗NB-ARC结构域抗体可用于发现抑制感染,自身免疫,炎症,过敏,同种异体移植排斥,败血症等的药物 疾病

    CARD-DOMAIN CONTAINING POLYPEPTIDES, ENCODING NUCLEIC ACIDS, AND METHODS OF USE
    7.
    发明申请
    CARD-DOMAIN CONTAINING POLYPEPTIDES, ENCODING NUCLEIC ACIDS, AND METHODS OF USE 审中-公开
    含有多核苷酸的多核苷酸,编码核酸的方法和使用方法

    公开(公告)号:US20110071213A1

    公开(公告)日:2011-03-24

    申请号:US12917295

    申请日:2010-11-01

    摘要: The invention provides caspase recruitment domain (CARD)-containing polypeptides and functional fragments thereof, encoding nucleic acid molecules, and specific antibodies. Also provided are screening methods for identifying CARD-associated polypeptides (CAPs), and for identifying agents that alter the association of a CARD-containing polypeptide with itself or with a CAP. Further provided are methods of altering a biochemical process modulated by a CARD-containing polypeptide, and methods of diagnosing a pathology characterized by an increased or decreased level of a CARD-containing polypeptide.

    摘要翻译: 本发明提供了含有胱天蛋白酶募集区(CARD)的多肽及其功能片段,编码核酸分子和特异性抗体。 还提供了用于鉴定CARD相关多肽(CAP)的筛选方法,以及用于鉴定改变含CARD的多肽与其自身或与CAP的缔合的试剂。 还提供了改变由含CARD的多肽调节的生物化学过程的方法,以及诊断特征在于含CARD的多肽的水平升高或降低的病理学的方法。

    Card-domain containing polypeptides, encoding nucleic acids, and methods of use
    8.
    发明授权
    Card-domain containing polypeptides, encoding nucleic acids, and methods of use 失效
    含有卡结构域的多肽,编码核酸和使用方法

    公开(公告)号:US07834149B2

    公开(公告)日:2010-11-16

    申请号:US11876595

    申请日:2007-10-22

    IPC分类号: C07K14/00

    摘要: The invention provides caspase recruitment domain (CARD)-containing polypeptides and functional fragments thereof, encoding nucleic acid molecules, and specific antibodies. Also provided are screening methods for identifying CARD-associated polypeptides (CAPs), and for identifying agents that alter the association of a CARD-containing polypeptide with itself or with a CAP. Further provided are methods of altering a biochemical process modulated by a CARD-containing polypeptide, and methods of diagnosing a pathology characterized by an increased or decreased level of a CARD-containing polypeptide.

    摘要翻译: 本发明提供了含有胱天蛋白酶募集区(CARD)的多肽及其功能片段,编码核酸分子和特异性抗体。 还提供了用于鉴定CARD相关多肽(CAP)的筛选方法,以及用于鉴定改变含CARD的多肽与其自身或与CAP的缔合的试剂。 还提供了改变由含CARD的多肽调节的生物化学过程的方法,以及诊断特征在于含CARD的多肽的水平升高或降低的病理学的方法。

    Bcl-G polypeptides, encoding nucleic acids and methods of use
    10.
    发明授权
    Bcl-G polypeptides, encoding nucleic acids and methods of use 失效
    Bcl-G多肽,编码核酸和使用方法

    公开(公告)号:US07638324B2

    公开(公告)日:2009-12-29

    申请号:US09738396

    申请日:2000-12-14

    摘要: The invention provides Bcl-G polypeptides and encoding nucleic acids. Bcl-G polypeptides include Bcl-GL and Bcl-GS. The invention also provides mouse Bcl-G. The invention also provides vectors containing Bcl-G nucleic acids, host cells containing such vectors, Bcl-G anti-sense nucleic acids and related compositions. The invention additionally provides Bcl-G oligonucleotides that can be used to hybridize to or amplify a Bcl-G nucleic acid. Anti-Bcl-G specific antibodies are also provided. Further provided are kits containing Bcl-G nucleic acids or Bcl-G specific antibodies. Such kits and reagents can be used to diagnose cancer, monitor response to therapy, or predict the prognosis of a cancer patient. The invention additionally provides methods of modulating apoptosis using Bcl-G polypeptides, encoding nucleic acids, or compounds that modulate the activity or expression of Bcl-G polypeptides. The methods for modulating apoptosis can be used to treat diseases such as cancer.

    摘要翻译: 本发明提供了Bcl-G多肽和编码核酸。 Bcl-G多肽包括Bcl-GL和Bcl-GS。 本发明还提供了小鼠Bcl-G。 本发明还提供含有Bcl-G核酸的载体,含有这些载体的宿主细胞,Bcl-G反义核酸和相关组合物。 本发明另外提供可用于与Bcl-G核酸杂交或扩增的Bcl-G寡核苷酸。 还提供抗Bcl-G特异性抗体。 还提供了含有Bcl-G核酸或Bcl-G特异性抗体的试剂盒。 这样的试剂盒和试剂可用于诊断癌症,监测对治疗的反应或预测癌症患者的预后。 本发明另外提供了使用调节Bcl-G多肽的活性或表达的Bcl-G多肽,编码核酸或化合物来调节凋亡的方法。 调节凋亡的方法可用于治疗癌症等疾病。